111 Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
111 Capital's ELV Position: Q2 2026 in Review
111 Capital increased its Elevance Health (ELV) stake by 94% in Q2 2026, buying an estimated $314K and bringing the position to 1,745 shares worth $675K. The position accounts for 0.12% of the portfolio, ranked #181.
111 Capital first reported a position in ELV in Q3 2025 and has held it in 3 quarters since. The position peaked at $820K in Q3 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- 111 Capital held 1,745 shares of Elevance Health worth $675K as of Q2 2026.
- 111 Capital bought 847 Elevance Health shares in Q2 2026, an estimated $314K.
- Elevance Health made up 0.12% of 111 Capital's portfolio in Q2 2026, its #181 holding.
- 111 Capital first reported a position in Elevance Health in Q3 2025 and has held it in 3 quarters since.
- 111 Capital's Elevance Health position peaked at $820K in Q3 2025.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.